Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pediatric diabetic ketoacidosis.
Lawrence S, Pacaud D, Dean H, Lawson M, Daneman D. Lawrence S, et al. Among authors: dean h. CMAJ. 2003 Aug 19;169(4):278-9; author reply 279. CMAJ. 2003. PMID: 12925411 Free PMC article. No abstract available.
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group. Knip M, et al. JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610. JAMA. 2014. PMID: 24915259 Free PMC article. Clinical Trial.
The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.
Lawson ML, Bradley B, McAssey K, Clarson C, Kirsch SE, Mahmud FH, Curtis JR, Richardson C, Courtney J, Cooper T, Downie CJ, Rajamannar G, Barrowman N; CGM TIME Trial Study Group; JDRF Canadian Clinical Trial Network CCTN1101. Lawson ML, et al. BMC Pediatr. 2014 Jul 18;14:183. doi: 10.1186/1471-2431-14-183. BMC Pediatr. 2014. PMID: 25034216 Free PMC article. Clinical Trial.
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.
Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group. Sosenko JM, et al. Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1. Diabetes Care. 2013. PMID: 23818528 Free PMC article.
Graves' disease in children.
Webster J, Taback SP, Sellers EA, Dean HJ. Webster J, et al. CMAJ. 2003 Jul 22;169(2):104-5. CMAJ. 2003. PMID: 12874154 Free PMC article. No abstract available.
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups. Sosenko JM, et al. Diabetes. 2013 Dec;62(12):4179-83. doi: 10.2337/db13-0656. Epub 2013 Jul 17. Diabetes. 2013. PMID: 23863814 Free PMC article.
Are children with type 1 diabetes immunocompromised?
Mustapha S, Sellers E, Dean H. Mustapha S, et al. Among authors: dean h. CMAJ. 2005 Aug 16;173(4):341. doi: 10.1503/cmaj.1050095. CMAJ. 2005. PMID: 16103492 Free PMC article. No abstract available.
466 results